Combination therapy with iron chelation and vancomycin in treating murine staphylococcemia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 33, Issue 5, 2014, Pages 845-851

  Luo, G ^a   Spellberg, B ^a,b   Gebremariam, T ^a   Lee, H ^a   Xiong, Y Q ^a,b   French, S W ^a,b   Bayer, A ^a,b   Ibrahim, A S ^a,b  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEFERASIROX; PLACEBO; VANCOMYCIN; ANTIINFECTIVE AGENT; BENZOIC ACID DERIVATIVE; CHELATING AGENT; IRON; TRIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL LOAD; BACTERIAL VIABILITY; CHELATION THERAPY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; FLOW CYTOMETRY; IN VITRO STUDY; IN VIVO STUDY; KIDNEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; STAPHYLOCOCCAL BACTEREMIA; TREATMENT OUTCOME; TREATMENT RESPONSE; VANCOMYCIN INTERMEDIATE STAPHYLOCOCCUS AUREUS; ANIMAL; BACTEREMIA; BAGG ALBINO MOUSE; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIAL VIABILITY; MICROBIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL LOAD; BENZOATES; CHELATING AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; IRON; KIDNEY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; SEVERITY OF ILLNESS INDEX; SPLEEN; STAPHYLOCOCCAL INFECTIONS; TREATMENT OUTCOME; TRIAZOLES; VANCOMYCIN;

EID: 84900820237     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-013-2023-5     Document Type: Article

References (34)

1. van Belkum A, Melles DC, Nouwen J, van Leeuwen WB, van Wamel W, Vos MC, Wertheim HF, Verbrugh HA (2009) Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus. Infect Genet Evol 9(1):32-47
2. Mertz PM, Cardenas TC, Snyder RV, Kinney MA, Davis SC, Plano LR (2007) Staphylococcus aureus virulence factors associated with infected skin lesions: influence on the local immune response. Arch Dermatol 143(10):1259-1263
3. Millar BC, Prendergast BD, Moore JE (2008) Community-associated MRSA (CA-MRSA): an emerging pathogen in infective endocarditis. J Antimicrob Chemother 61(1):1-7
4. Saavedra-Lozano J, Mejías A, Ahmad N, Peromingo E, Ardura MI, Guillen S, Syed A, Cavuoti D, Ramilo O (2008) Changing trends in acute osteomyelitis in children: impact of methicillin-resistant Staphylococcus aureus infections. J Pediatr Orthop 28(5):569-575
5. Pittet D, Wenzel RP (1995) Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med 155(11):1177-1184
6. Hammer ND, Skaar EP (2011) Molecular mechanisms of Staphylococcus aureus iron acquisition. Annu Rev Microbiol 65:129-147
7. Mazmanian SK, Skaar EP, Gaspar AH, Humayun M, Gornicki P, Jelenska J, Joachmiak A, Missiakas DM, Schneewind O (2003) Passage of heme-iron across the envelope of Staphylococcus aureus. Science 299(5608):906-909
8. Mack J, Vermeiren C, Heinrichs DE, Stillman MJ (2004) In vivo heme scavenging by Staphylococcus aureus IsdC and IsdE proteins. Biochem Biophys Res Commun 320(3):781-788
9. Skaar EP, Schneewind O (2004) Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme. Microbes Infect 6(4):390-397
10. Tiedemann MT, Heinrichs DE, Stillman MJ (2012) Multiprotein heme shuttle pathway in Staphylococcus aureus: iron-regulated surface determinant cog-wheel kinetics. J Am Chem Soc 134(40):16578-16585
11. Konetschny-Rapp S, Jung G, Meiwes J, Zähner H (1990) Staphyloferrin A: a structurally new siderophore from staphylococci. Eur J Biochem 191(1):65-74
12. Drechsel H, Freund S, Nicholson G, Haag H, Jung O, Zähner H, Jung G (1993) Purification and chemical characterization of staphyloferrin B, a hydrophilic siderophore from staphylococci. Biometals 6(3):185-192
13. Courcol RJ, Trivier D, Bissinger MC, Martin GR, Brown MR (1997) Siderophore production by Staphylococcus aureus and identification of iron-regulated proteins. Infect Immun 65(5):1944-1948
14. Modun B, Williams P (1999) The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun 67(3):1086-1092
15. Singh N, Sun HY (2008) Iron overload and unique susceptibility of liver transplant recipients to disseminated disease due to opportunistic pathogens. Liver Transpl 14(9):1249-1255
16. Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE Jr, Spellberg BJ (2007) The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest 117(9):2649-2657
17. Ibrahim AS, Gebremariam T, French SW, Edwards JE Jr, Spellberg B (2010) The iron chelator deferasirox enhances liposomal amphotericin B efficacy in treating murine invasive pulmonary aspergillosis. J Antimicrob Chemother 65(2):289-292
18. Ibrahim AS, Gebremariam T, Luo G, Fu Y, French SW, Edwards JE Jr, Spellberg B (2011) Combination therapy of murine mucormycosis or aspergillosis with iron chelation, polyenes, and echinocandins. Antimicrob Agents Chemother 55(4):1768-1770
19. Clinical and Laboratory Standards Institute (CLSI) (2009) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI, Wayne, PA
20. Lemaire S, Kosowska-Shick K, Julian K, Tulkens PM, Van Bambeke F, Appelbaum PC (2008) Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis. Clin Microbiol Infect 14(8):766-777
21. Xiong YQ, Van Wamel W, Nast CC, Yeaman MR, Cheung AL, Bayer AS (2002) Activation and transcriptional interaction between agr RNAII and RNAIII in Staphylococcus aureus in vitro and in an experimental endocarditis model. J Infect Dis 186(5):668-677
22. Xiong YQ, Willard J, Yeaman MR, Cheung AL, Bayer AS (2006) Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 194(9):1267-1275
23. Hilliard JJ, Fernandez J, Melton J, Macielag MJ, Goldschmidt R, Bush K, Abbanat D (2009) In vivo activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457. Antimicrob Agents Chemother 53(5):2028-2033
24. Pistella E, Falcone M, Baiocchi P, Pompeo ME, Pierciaccante A, Penni A, Venditti M (2005) In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Infez Med 13(2):97-102
25. Shelburne SA, Musher DM, Hulten K, Ceasar H, Lu MY, Bhaila I, Hamill RJ (2004) In vitro killing of community-associated methicillin-resistant Staphylococcus aureus with drug combinations. Antimicrob Agents Chemother 48(10):4016-4019
26. Allen GP, Cha R, Rybak MJ (2002) In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob Agents Chemother 46(8):2606-2612
27. Eliopoulos GM, Thauvin C, Gerson B, Moellering RC Jr (1985) In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic. Antimicrob Agents Chemother 27(3):357-362
28. Attaran S, Wragg A, Awad WI (2011) Aortic valve endocarditis with splenic and brain abscesses: difficult management issues. Heart Surg Forum 14(2):E139-E141
29. Goldwater PN (2009) Sterile site infection at autopsy in sudden unexpected deaths in infancy. Arch Dis Child 94(4):303-307
30. Alexander J, Limaye AP, Ko CW, Bronner MP, Kowdley KV (2006) Association of hepatic iron overload with invasive fungal infection in liver transplant recipients. Liver Transpl 12(12):1799-1804
31. Weiss G, Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner-Felmayer G, Wachter H (1992) Iron modulates interferon-gamma effects in the human myelomonocytic cell line THP-1. Exp Hematol 20(5):605-610
32. Skaar EP, Gaspar AH, Schneewind O (2004) IsdG and IsdI, heme-degrading enzymes in the cytoplasm of Staphylococcus aureus. J Biol Chem 279(1):436-443
33. Nick H, Wong A, Acklin P, Faller B, Jin Y, Lattmann R, Sergejew T, Hauffe S, Thomas H, Schnebli HP (2002) ICL670A: preclinical profile. Adv Exp Med Biol 509:185-203
34. Nisbet-Brown E, Olivieri NF, Giardina PJ, Grady RW, Neufeld EJ, Séchaud R, Krebs-Brown AJ, Anderson JR, Alberti D, Sizer KC, Nathan DG (2003) Effectiveness and safety of ICL670 in iron-loaded patients with thalassaemia: a randomised, double-blind, placebo-controlled, dose-escalation trial. Lancet 361(9369):1597-1602